Onena Medicines

Private

AllschwilHealthcare & Life Scienceshttps://www.onenameds.com/

Last Round

Series A

Oct 31, 2023

Total Funding Raised

$6.57M

Company Overview

Onena Medicines is a biopharmaceutical company that utilizes an AI-centric platform for discovering and developing antibody-based medicines to treat recurrent and metastatic cancers and select rare diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

antibody therapydrug discoverybiotechAI drug discoveryin silico drug discoveryprecision medicineantibody designDSIP neutralizationbiopharmapreclinical biotechAI-driven medicinecomputational biologytherapeutic antibodydrug pipelinebiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Onena Medicines Comparables

Compare Onena Medicines with similar companies based on industry and business-model similarity.

Onena Medicines comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Onena Medicines Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Oct 31, 2023
Grant	Mar 1, 2023
Accelerator	Feb 1, 2022
Seed	Mar 1, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Neethan Lobo

CEO And Co-founder

Founding Team

Onena Medicines Investors

Notable investors and investment history

Onena Medicines investors
Investor	Rounds
Avanteca Partners	Series A
DeepTek Gipuzkoa Fundazioa	Seed
BaseLaunch	Accelerator
Zurcher Kantonalbank	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Oct 31, 2023
$4M round led by Zurcher Kantonalbank and Avanteca Partners
Feb 1, 2022
$540K raised from BaseLaunch

View all signals

Onena Medicines Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Onena Medicines Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Onena Medicines's valuation, stock price, and market status.

Firmographic Details

HeadquartersAllschwil

Employee Range9

Year Founded2019

Last FundingOct 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.